Evidence map›Paper›PMID 40273160›Full record

ArticlePloS one2025

Effect on preoperative anxiety of a personalized three-dimensional kidney model prior to nephron-sparing surgery for renal tumor: study protocol for a randomized controlled trial (Rein 3D Print-Anxiety - UroCCR 113).

Alice Pitout, Gaëlle Margue, Joffrey Sarrazin, Laura Richert, Hugo Larribère, Sarah Masanet, Thibaut Waeckel, Pierre Bigot, Romain Boissier, Bastien Parier and 8 more

Abstract readClinical Trial Protocol
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Alice PitoutDepartment of Urology, University Hospital, Bordeaux, France.ORCID 0000-0003-4939-3549
Gaëlle MargueDepartment of Urology, University Hospital, Bordeaux, France.
Joffrey SarrazinDepartment of Additive Fabrication Engineering, TechnoShop Coh@bit, Bordeaux University Technological Institute, Gradignan, France.
Laura RichertMedical Information Department, University Hospital, Bordeaux cedex, France.
Hugo LarribèreDepartment of Additive Fabrication Engineering, TechnoShop Coh@bit, Bordeaux University Technological Institute, Gradignan, France.
Sarah MasanetCulture et Diffusion des Savoirs EA-7440, Bordeaux University, Bordeaux, France.
Thibaut WaeckelDepartment of Urology, University Hospital, Caen, France.ORCID 0000-0002-5775-479X
Pierre BigotDepartment of Urology, University Hospital, Angers, France.
Romain BoissierAix Marseille University, Department of Urology and Transplantation, University hospital La Conception, AP-HM, Marseille, France.
Bastien ParierDepartment of Urology, Hôpital Bicêtre, AP-HP, Paris, France.
Stéphane De VergieDepartment of Urology, University Hospital, Nantes, France.ORCID 0000-0002-6308-602X
Manon JaffredoDepartment of Urology, University Hospital, Bordeaux, France.
Solène RicardDepartment of Urology, University Hospital, Bordeaux, France.
Hélène HoarauCulture et Diffusion des Savoirs EA-7440, Bordeaux University, Bordeaux, France.
Marthe-Aline JutandCulture et Diffusion des Savoirs EA-7440, Bordeaux University, Bordeaux, France.
Matthieu FaesselDepartment of Additive Fabrication Engineering, TechnoShop Coh@bit, Bordeaux University Technological Institute, Gradignan, France.
Jocelyn SabatierDepartment of Additive Fabrication Engineering, TechnoShop Coh@bit, Bordeaux University Technological Institute, Gradignan, France.
Jean-Christophe BernhardDepartment of Urology, University Hospital, Bordeaux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe announcement of a diagnosis can be a source of anxiety for patients. Managing this anxiety is a major challenge, in terms of quality of life but also for the use of anxiolytic and analgesic therapies. The use of 3D modeling technology in partial nephrectomy surgery has proved its worth as a surgical aid but it could also help patients to manage their own care, by reducing their anxiety and increasing their understanding of the disease and its treatment. We aim to test this hypothesis with a prospective multicenter trial.

methodsR3DP-A (Rein 3D - Anxiety) is an unblinded, multicenter, randomized, prospective, superiority-controlled trial. Participants are patients with kidney tumors treated by robot-assisted partial laparoscopic nephrectomy. The 234 patients (78x3 groups) from 6 French centers will undergo a pre-operative consultation dedicated to a personalized explanation of the surgical management and its risks. They will be randomized into three (1:1:1) groups corresponding to three types of support for consultation: use of a virtual 3D model of the kidney and its tumor; a printed 3D model; or the standard information sheet from the French Association of Urology (control group). Several self-questionnaires will be sent by the UroConnect® application and completed at different times during the study. The primary endpoint will be pre-operative anxiety (STAI-state questionnaire completed the day before surgery D-1). Secondary endpoints will be changes in anxiety levels between the pre-operative and post-operative consultations (between inclusion and D15 post-op), changes in health literacy and quality of life (HLSEU-Q16 and EQ-5D-5L questionnaires at inclusion and D15), feelings of understanding of the disease and its treatment at pre-operative period (Wake questionnaire at D-1), and consultation times. DISCUSSION: We aim to highlight a benefit of using a personalized 3D model on the anxiety level of patients undergoing partial nephrectomy surgery, as well as on their level of understanding of their pathology and its surgical treatment. The use of these models could be incorporated into current practice to improve patient experience throughout care.

Indexed as

AnxietyKidneyKidney NeoplasmsNephrectomyPrinting, Three-DimensionalEquivalence Trials as TopicFemaleHumansMaleMulticenter Studies as TopicProspective StudiesQuality of LifeRandomized Controlled Trials as Topic

Identifiers

PMID40273160
PMCPMC12021170

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.